240 related articles for article (PubMed ID: 24186915)
21. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
[TBL] [Abstract][Full Text] [Related]
22. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis.
Rodseth RN; Biccard BM; Le Manach Y; Sessler DI; Lurati Buse GA; Thabane L; Schutt RC; Bolliger D; Cagini L; Cardinale D; Chong CP; Chu R; Cnotliwy M; Di Somma S; Fahrner R; Lim WK; Mahla E; Manikandan R; Puma F; Pyun WB; Radović M; Rajagopalan S; Suttie S; Vanniyasingam T; van Gaal WJ; Waliszek M; Devereaux PJ
J Am Coll Cardiol; 2014 Jan; 63(2):170-80. PubMed ID: 24076282
[TBL] [Abstract][Full Text] [Related]
23. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
25. Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis.
Wang F; Wu Y; Tang L; Zhu W; Chen F; Xu T; Bo L; Li J; Deng X
Crit Care; 2012 May; 16(3):R74. PubMed ID: 22559153
[TBL] [Abstract][Full Text] [Related]
26. Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration.
Sivalingam M; Suresh M; Farrington K
Hemodial Int; 2011 Jul; 15(3):359-65. PubMed ID: 21624043
[TBL] [Abstract][Full Text] [Related]
27. Association of NT-proBNP and BNP With Future Clinical Outcomes in Patients With ESKD: A Systematic Review and Meta-analysis.
Harrison TG; Shukalek CB; Hemmelgarn BR; Zarnke KB; Ronksley PE; Iragorri N; Graham MM; James MT
Am J Kidney Dis; 2020 Aug; 76(2):233-247. PubMed ID: 32387090
[TBL] [Abstract][Full Text] [Related]
28. Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure.
Hebl V; Zakharova MY; Canoniero M; Duprez D; Garcia S
Vasc Health Risk Manag; 2012; 8():213-8. PubMed ID: 22536076
[TBL] [Abstract][Full Text] [Related]
29. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.
Balion C; Santaguida PL; Hill S; Worster A; McQueen M; Oremus M; McKelvie R; Booker L; Fagbemi J; Reichert S; Raina P
Evid Rep Technol Assess (Full Rep); 2006 Sep; (142):1-147. PubMed ID: 17764210
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y
J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914
[TBL] [Abstract][Full Text] [Related]
31. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
[TBL] [Abstract][Full Text] [Related]
33. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
Natriuretic Peptides Studies Collaboration ; Willeit P; Kaptoge S; Welsh P; Butterworth AS; Chowdhury R; Spackman SA; Pennells L; Gao P; Burgess S; Freitag DF; Sweeting M; Wood AM; Cook NR; Judd S; Trompet S; Nambi V; Olsen MH; Everett BM; Kee F; Ärnlöv J; Salomaa V; Levy D; Kauhanen J; Laukkanen JA; Kavousi M; Ninomiya T; Casas JP; Daniels LB; Lind L; Kistorp CN; Rosenberg J; Mueller T; Rubattu S; Panagiotakos DB; Franco OH; de Lemos JA; Luchner A; Kizer JR; Kiechl S; Salonen JT; Goya Wannamethee S; de Boer RA; Nordestgaard BG; Andersson J; Jørgensen T; Melander O; Ballantyne ChM; DeFilippi Ch; Ridker PM; Cushman M; Rosamond WD; Thompson SG; Gudnason V; Sattar N; Danesh J; Di Angelantonio E
Lancet Diabetes Endocrinol; 2016 Oct; 4(10):840-9. PubMed ID: 27599814
[TBL] [Abstract][Full Text] [Related]
34. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
35. N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke.
Chang L; Yan H; Li H; Song Z; Gui Y; Yan Z; Li T; Duan D
Neuroreport; 2014 Sep; 25(13):985-90. PubMed ID: 25102374
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
Wayne Causey M; Singh N
Semin Vasc Surg; 2014 Dec; 27(3-4):143-7. PubMed ID: 26073822
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis.
Wei XB; Liu YH; He PC; Yu DQ; Zhou YL; Tan N; Chen JY
Eur J Prev Cardiol; 2017 May; 24(7):676-684. PubMed ID: 28067531
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
[TBL] [Abstract][Full Text] [Related]
39. Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure.
Rosenberg J; Gustafsson F; Remme WJ; Riegger GA; Hildebrandt PR
Cardiovasc Drugs Ther; 2008 Aug; 22(4):305-11. PubMed ID: 18309461
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias.
Levine YC; Rosenberg MA; Mittleman M; Samuel M; Methachittiphan N; Link M; Josephson ME; Buxton AE
Heart Rhythm; 2014 Jul; 11(7):1109-16. PubMed ID: 24837348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
